e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Treatment options and tumour biology of malignant pleural mesothelioma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Epithelial-to-mesenchymal transition in malignant mesothelioma
A. Diaz-Baquero, B. Romero Romero, L. Gomez-Izquierdo, R. Avila Polo, J. Martin-Juan, F. Rodriguez-Panadero (Seville, Spain)
Source:
Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Session:
Treatment options and tumour biology of malignant pleural mesothelioma
Session type:
Oral Presentation
Number:
2950
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Diaz-Baquero, B. Romero Romero, L. Gomez-Izquierdo, R. Avila Polo, J. Martin-Juan, F. Rodriguez-Panadero (Seville, Spain). Epithelial-to-mesenchymal transition in malignant mesothelioma. Eur Respir J 2011; 38: Suppl. 55, 2950
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Multimodality treatment of malignant pleural mesothelioma
Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Year: 2011
All-
trans
-retinoic acid inhibits tumor growth of malignant pleural mesothelioma in mice
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Dissecting the mTOR pathway in malignant pleural mesothelioma
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Pleural atypical mesothelial hyperplasia: An early stage of pleural malignant mesothelioma?
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012
Effects of mTOR Inhibition in malignant mesothelioma
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Indolent lung cancers
Source: Annual Congress 2011 - Slow-growing lung cancer
Year: 2011
Epithelial mesenchymal transition
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Malignant mesothelioma
Source: ERS Skills Course 2018 - Thoracoscopy and pleural techniques
Year: 2018
How to develop a pleural service
Source: Annual Congress 2011 - PG16 Thoracic ultrasound for physicians
Year: 2011
Dealing with diagnosis of benign and malignant pleural effusions
Source: Annual Congress 2010 - PG5 Postgraduate Course: Interventional thoracoscopy
Year: 2010
Osteopontin of either host or tumor origin critically affects malignant pleural effusion formation
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Proliferative intercellular signalling pathway in human malignant mesothelioma cells
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Thoracoscopy and malignant pleural mesothelioma
Source: ERS Course 2015
Year: 2015
Small-cell lung cancer and mesothelioma: diagnosis and management
Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course
Year: 2011
Malignant mesothelioma of pleura
Source: Eur Respir J 2002; 20: Suppl. 38, 40s
Year: 2002
Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017
Survival time in patients with malignant pleural mesothelioma
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007
Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept